prosaptide (Human) [6479]
prosaptide (Human)
| SMILES |
CCC(C)C(NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCC(=O)O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(CC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CC(=O)O)NC(=O)C(NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(NC(=O)C(NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(NC(=O)C(CC(C)C)NC(=O)C(Cc1ccccc1)NC(=O)C(CCC(=O)O)NC(=O)C(N)CS)C(C)C)C(C)C)C(C)O)C(C)CC)C(C)O)C(=O)NC(CC(C)C)C(=O)O |
| InChIKey |
KSDDQEGWVBODMD-UHFFFAOYSA-N |
| Sequence |
CEFLVKEVTKLIDNNKTEKEIL |
| HELM |
PEPTIDE1{C.E.F.L.V.K.E.V.T.K.L.I.D.N.N.K.T.E.K.E.I.L}$$$$ |
Chemical Properties
| Hydrogen bond acceptors |
None |
| Hydrogen bond donors |
None |
| Rotatable bonds |
None |
| Log P |
None |
| Molecular weight (Da) |
None |
No bioactivity data available.
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.